Fri, May 16, 2025
Volume 18, Issue 6 (Nov-Dec 2024)
mljgoums 2024, 18(6): 12-14 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Uzma F J, L S, S P. Overdiagnosis of epithelial abnormalities in atrophic cervical pap smears unmasking overdiagnosis in atrophic pap smears. mljgoums 2024; 18 (6) :12-14
URL: http://mlj.goums.ac.ir/article-1-1734-en.html
URL: http://mlj.goums.ac.ir/article-1-1734-en.html
1- Department of Pathology, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, India , fasahatuzma@gmail.com
2- Department of Pathology, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, India
2- Department of Pathology, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, India
Abstract: (873 Views)
Background: Cervical cancer has seen a significant decline in death rates due to early diagnosis and treatment. The Pap test remains valuable but exhibits limitations, such as false positives and false negatives, with the former associated with atrophy-related changes. This article aims to bring attention to cervical carcinoma screening, focusing on the interpretation of atrophy-related changes in Pap smears and minimizing intervention.
Methods: This retrospective study, conducted at a tertiary care center, evaluated cases with intra-epithelial abnormalities or malignancies in Pap smears.
Results: A total of 11,680 cervical cytology smears received in the Department of Pathology, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, over 7.5 years (From January 1, 2016, to June 30, 2023), were reviewed. Of these, 56 cases exhibited epithelial abnormalities and were categorized as follows: 1. Atypical squamous cells of undetermined significance, 2. Low-grade squamous intraepithelial lesion, 3. High-grade squamous intraepithelial lesion, and 4. Malignancy. Among the 56 smears, 40 (71%) showed co-existent atrophy. Biopsies were available for 22 smears, and atrophy with epithelial abnormalities co-existed in 16 (28%) of these cases. Of these 16 cases, only eight (50%) were found to have abnormalities greater than Cervical Intraepithelial Neoplasia II dysplasia. This results in the positive predictive value of cervical cytology smears detecting epithelial abnormalities in cases with co-existing atrophy-related changes being only 50%.
Conclusion: The article emphasizes the importance of cautious interpretation of Pap smears in the presence of atrophy.
Methods: This retrospective study, conducted at a tertiary care center, evaluated cases with intra-epithelial abnormalities or malignancies in Pap smears.
Results: A total of 11,680 cervical cytology smears received in the Department of Pathology, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, over 7.5 years (From January 1, 2016, to June 30, 2023), were reviewed. Of these, 56 cases exhibited epithelial abnormalities and were categorized as follows: 1. Atypical squamous cells of undetermined significance, 2. Low-grade squamous intraepithelial lesion, 3. High-grade squamous intraepithelial lesion, and 4. Malignancy. Among the 56 smears, 40 (71%) showed co-existent atrophy. Biopsies were available for 22 smears, and atrophy with epithelial abnormalities co-existed in 16 (28%) of these cases. Of these 16 cases, only eight (50%) were found to have abnormalities greater than Cervical Intraepithelial Neoplasia II dysplasia. This results in the positive predictive value of cervical cytology smears detecting epithelial abnormalities in cases with co-existing atrophy-related changes being only 50%.
Conclusion: The article emphasizes the importance of cautious interpretation of Pap smears in the presence of atrophy.
Research Article: Research Article |
Subject:
Pathology
Received: 2023/10/11 | Accepted: 2024/04/29 | Published: 2024/12/16 | ePublished: 2024/12/16
Received: 2023/10/11 | Accepted: 2024/04/29 | Published: 2024/12/16 | ePublished: 2024/12/16
References
1. Li Y, ShoyeIe O, Shidham V B. Pattern of cervical biopsy in cases with cervical cytology interpreted as higher than low grade in the background with atrophic cellular changes. CytoJournaI. 2020; 17: 12. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. He WQ, Li C. Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends. Gynecol Oncol. 2021; 163(3): 583-592. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Sachan PL, Singh M, Patel ML, Sachan R. A Study on Cervical Cancer Screening Using Pap Smear Test and Clinical Correlation. Asia Pac J Oncol Nurs. 2018; 5(3): 337-341. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Kumar V, Abbas A, Aster J C. Robbins & Cotran Pathological Basis of Disease. 10th edition. Philadelphia : Elsevier ; 2020: 996-1001. [View at Publisher]
5. Stoler MH, Jenkins D, Bergeron C. The pathology of cervical precancer and cancer and its importance in clinical practice. InHuman Papillomavirus. Academic Press. 2020; 85-109. [View at Publisher] [Google Scholar]
6. DeMay RM. Cytopathology of false negatives preceding cervical carcinoma. Am. J. Obstet. Gynecol. 1996; 175: 1110–1113. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Nayar R. Wilbur David. The Bethesda system for reporting Cervical Cytology .4th edition. New York and London : Springer ; 2015. pp 18-54. [DOI] [Google Scholar]
8. Vrdoljak-Mozetič D, Štemberger-Papić S, Verša Ostojić D, Rubeša R, Klarić M, Eminović S. Pitfalls in Gynecological Cytology: Review of the Common and Less Frequent Entities in Pap Test. Acta Cytol. 2024; 68(3): 281-298. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Patton AL, Duncan L, Bloom Phaneuf G, Zafar N. Atypical squamous cells, cannot exclude a high-grade intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive-use patients. Cancer . 2008; 114:481 - 8. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Bulten J, de Wilde PC, Boonstra H, Gemmink JH, Hanselaar AG. Proliferation in "atypical" atrophic pap smears. Gynecol Oncol . 2000 ; 79 : 225-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Tabrizi AD. Atrophic Pap smears, differential diagnosis and pitfalls: A review. Int J Women's Health Reprod Sci . 2017 ; 6: 2-5. [View at Publisher] [DOI] [Google Scholar]
12. Crothers BA, Booth CN, Darragh TM, Means MM, Souers RJ, Thomas N, et al. Atrophic vaginitis: Concordance and interpretation of slides in the college of american pathologists cervicovaginal interlaboratory comparison program in gynaecologic cytopathology . Arch Pathol Lab Med . 2012 ; 136 : 1332-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.